Resources

Canadian Public Reimbursement Timelines

One of Innovative Medicines Canada’s guiding principles is to offer solutions to challenges in the Canadian health system. Access to new medicines is one such challenge.

One of Innovative Medicines Canada’s guiding principles is to offer solutions that address challenges in the Canadian health system; access to new medicines is one such challenge.

We believe that information-sharing is essential to collaboratively finding solutions and ensuring the sustainability of Canadian health systems.

Toward this effort, Innovative Medicines Canada (IMC) has put together a pCPA Trends Update page to provide drug reimbursement updates and trends in Canada and OECD countries.

These resources are prepared and updated by IMC using aggregated and independently collected data. Sources include data from IQVIA International Reimbursement Comparison, Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), Institut national d’excellence en santé et services sociaux (INESSS), pan-Canadian Pharmaceutical Alliance (pCPA), and various Canadian provincial formularies.

Trends related to time to access, volume of negations, and pCPA performance metrics are identified.

pCPA timeline data

This does not include drugs where negotiations were not pursued or subsequent pCPA attempts after the first attempt.
Source: IMC analysis of pCPA data collected from pCPA Canada and CADTH data collected from CADTH Reimbursement Review Reports.
Source: IMC analysis of pCPA data collected from pCPA Canada and CADTH data collected from CADTH Reimbursement Review Reports.
This does not include drugs where negotiations were not pursued or subsequent pCPA attempts after the first attempt.
Source: IMC analysis of pCPA data collected from https://www.pcpacanada.ca/negotiations and CADTH data collected from CADTH Reimbursement Review Reports.
Source: IMC analysis of pCPA data collected from pCPA Canada.
Source: IMC analysis of pCPA data collected from pCPA Canada.
pCPA files with a CADTH Project Number entry of « Not Applicable » were not included when estimating time to pCPA engagement, but were included when estimating the duration of pCPA negotiations. % of negotiations on BPG target include files where both time to LOE and time to LOI could be estimated. Includes only pCPA files negotiated with an LOI.
Source: IMC analysis of pCPA data collected from pCPA Canada.

resources

Discover. Learn.
Understand.

Informative content to keep you up to date on the most pressing issues facing our industry.